REQUEST A DEMO
Total
USD $0.00
Search more companies

Pell Bio-Med Technology Co. Ltd. (Taiwan, China)

Main Activities: Research and Development in Nanotechnology
Full name: Pell Bio-Med Technology Co. Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Pell Bio-Med Technology Co. Ltd. is a company in Taiwan, China, with a head office in Taipei City. The enterprise operates in the Research and Development in Nanotechnology industry. The company was established on April 01, 2026. The company’s latest financial report indicates a net sales revenue increase of 69.11% in Q3C2025. Over the same period, its total assets decreased by 0.27%. In, 2025, the company’s net profit margin increased by 818.27%.

Headquarters
Neihu Dist4F.,No.87,Xinhu 2Nd Rd
Taipei City; Taipei City;

Contact Details: Purchase the Pell Bio-Med Technology Co. Ltd. report to view the information.

Website: http://www.pellbmt.com

Basic Information
Outstanding Shares:
Purchase the Pell Bio-Med Technology Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Pell Bio-Med Technology Co. Ltd. report to view the information.
Incorporation Date:
April 01, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
10.23%
Purchase this report to view the information.
7.12%
Purchase this report to view the information.
4.52%
Purchase this report to view the information.
3.85%
Purchase this report to view the information.
3.61%
Subsidiaries
鉑森生技股份有限公司
100%
台灣細胞製造股份有限公司
70%
Company Performance
Financial values in the chart are available after Pell Bio-Med Technology Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
69.11%
Total Operating Revenue
26.78%
Operating Profit
4.71%
EBITDA
3.56%
Net Profit/Loss for the Period
2.07%
Total Assets
-0.27%
Total Equity
-10.44%
Operating Profit Margin
879.02%
Net Profit Margin
818.27%
Return on Equity (ROE)
-1.98%
Debt / Equity
7331%
Quick Ratio
-8478.79%
Cash Ratio
-5.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?